Ушбу иш иқтибос қилган ишлар

161 та иш

Иш: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

The metabolic addiction of cancer stem cells
Om Saswat Sahoo, Karthikeyan Pethusamy, Tryambak P. Srivastava +5
Шарҳ мақола20222 иқтибос
ABI
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Ziyi Zhao, Yong Mei, Ziyang Wang +1
Шарҳ мақола20222 иқтибос
ABI
Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Qiaolin Liu, Yuliang Zhao, Huige Zhou +1
Шарҳ мақола20232 иқтибос
ABI
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Karan Chohan, Elizabeth L. Siegler, Saad S. Kenderian
Шарҳ мақола20232 иқтибос
ABI
Co-opting signalling molecules enables logic-gated control of CAR T cells
Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh +15
Мақола20232 иқтибос
ABI
OXPHOS-targeting drugs in oncology: new perspectives
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy +1
Шарҳ мақола20232 иқтибос
ABI
Amino acid metabolism in tumor biology and therapy
Jie Chen, Likun Cui, Shaoteng Lu +1
Мақола20242 иқтибос
ABI
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu +5
Мақола20242 иқтибос
ABI
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang +3
Мақола20242 иқтибос
ABI
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
Yufei Wang, Alicia Buck, Brandon Piel +26
Мақола20242 иқтибос
ABI
Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma
James J. Wu, Armin Ghobadi, Richard T. Maziarz +6
Мақола20242 иқтибос
ABI
Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening
Chengfang Zhou, Mei Kuang, Tao Yin +12
Мақола20242 иқтибос
ABI
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
Yan Zhong, Jingfeng Liu
Мақола20242 иқтибос
ABI
Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment
Manish Kumar Singh, Sunhee Han, Sung Soo Kim +1
Шарҳ мақола20242 иқтибос
ABI
Artificial Intelligence for Neuroimaging in Pediatric Cancer
Josué Luiz Dalboni da Rocha, Jesyin Lai, Pankaj Pandey +4
Шарҳ мақола20252 иқтибос
ABI
EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies
Chuan‐Hsin Chang, Chung‐Che Tsai, Fu‐Ming Tsai +3
Шарҳ мақола20252 иқтибос
ABI
Artificial intelligence in cancer pathology: Applications, challenges, and future directions
Jiu-Le Wang, Teng Wang, Rui Han +2
Шарҳ мақола20252 иқтибос
ABI
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
Martina Milella, Monica Rutigliano, Savio Domenico Pandolfo +7
Шарҳ мақола20252 иқтибос
ABI
Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing
J. H. Isaacson, Prajakta Bhanap, Nicholas H. Putnam +7
Мақола20252 иқтибос
ABI
Targeting glutamine metabolism as a potential target for cancer treatment
Wenxuan Zou, Zitao Han, Zihan Wang +1
Шарҳ мақола20252 иқтибос
ABI
Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives
Sarkar Sardar Azeez, Raya Kh. Yashooa, Shukur Wasman Smail +4
Шарҳ мақола20252 иқтибос
ABI
Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy
Gyas Khan, Ali Hanbashi, Wedad Mawkili +7
Мақола20252 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI